JASON WARCZINSKY: Open Payments
NPI 1053904805 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,258 in 55 payments from 19 companies in 2025. Trend: 2023 $2,188 · 2024 $1,895 · 2025 $1,258
Food & beverage: $1,158Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $220 |
| Merck Sharp & Dohme LLC | 6 | $184 |
| Sumitomo Pharma America, Inc. | 10 | $160 |
| Boston Scientific Corporation | 2 | $87 |
| ABBVIE INC. | 4 | $82 |
| Dendreon Pharmaceuticals LLC | 3 | $75 |
| COLOPLAST CORP | 2 | $61 |
| Janssen Biotech, Inc. | 4 | $60 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $51 |
| PFIZER INC. | 3 | $47 |
Products named: KEYTRUDA, XTANDI, ORGOVYX, SpaceOAR VUE System - 10mL, BOTOX, PROVENGE, ERLEADA, JOURNAVX.
Industry payments across MI — which companies pay providers there.
